国际眼科纵览2024,Vol.48Issue(2) :103-108.DOI:10.3760/cma.j.issn.1673-5803.2024.02.005

环孢素在围手术期干眼症防治中的研究进展

Advances in the prevention and treatment of perioperative dry eye disease with cyclosporine

韩艺琳 张凤妍
国际眼科纵览2024,Vol.48Issue(2) :103-108.DOI:10.3760/cma.j.issn.1673-5803.2024.02.005

环孢素在围手术期干眼症防治中的研究进展

Advances in the prevention and treatment of perioperative dry eye disease with cyclosporine

韩艺琳 1张凤妍1
扫码查看

作者信息

  • 1. 郑州大学第一附属医院眼科,郑州 450000
  • 折叠

摘要

干眼症是一种常见的多因素眼表疾病,与眼表炎症、泪膜不稳定等有关.近年来,大量研究表明围手术期用药、手术创伤、患者自身因素、术后炎性反应等与围手术期干眼症相关.环孢素可选择性地调节T细胞,保护杯状细胞与结膜上皮细胞并促进泪液分泌,从而有效缓解患者干眼症状,提高手术精确度与患者满意度.目前环孢素已被广泛应用于围手术期干眼症的临床治疗中,并取得良好效果.(国际眼科纵览,2024,48:103-108)

Abstract

Dry eye disease(DED)is a multifactorial and prevalent disease associated with ocular surface inflammation and impaired lubrication.In recent years,numerous studies have demonstrated that perioperative pharmacological use,surgical trauma,individual factors,and postoperative inflammatory re-sponses are associated with postoperative DED.Cyclosporine selectively regulates T cells,protecting goblet cells and conjunctival epithelial cells while promoting tear secretion.As a result,it effectively alleviates dry eye symptoms in patients,improving the precision of surgeries and patient satisfaction.Currently,cyclospo-rine is widely used in the clinical treatment of perioperative dry eye,achieving favorable outcomes.(Int Rev Ophthalmol,2024,48:103-108)

关键词

环孢素/干眼症/围手术期

Key words

cyclosporine/dry eye disease/perioperative period

引用本文复制引用

基金项目

国家自然科学基金(81970785)

出版年

2024
国际眼科纵览
中华医学会 北京市眼科研究所

国际眼科纵览

影响因子:0.243
ISSN:1673-5803
参考文献量53
段落导航相关论文